Analysts Conflicted on These Healthcare Names: Aveanna Healthcare Holdings (AVAH) and BioNTech SE (BNTX)
Truist Financial Maintains Aveanna Healthcare(AVAH.US) With Hold Rating, Announces Target Price $6
Truist Financial Reaffirms Their Hold Rating on Aveanna Healthcare Holdings (AVAH)
UBS Maintains Aveanna Healthcare(AVAH.US) With Sell Rating, Raises Target Price to $3.2
UBS Adjusts Price Target on Aveanna Healthcare to $3.20 From $2.80, Maintains Sell Rating
Deutsche Bank Maintains Aveanna Healthcare(AVAH.US) With Buy Rating, Raises Target Price to $7
Truist Financial Initiates Aveanna Healthcare(AVAH.US) With Hold Rating
Truist Financial Keeps Their Hold Rating on Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare Hldgs Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: GeoVax Labs (GOVX), Akebia Therapeutics (AKBA) and Aveanna Healthcare Holdings (AVAH)
Press Release: Aveanna Healthcare Holdings Announces Second Quarter 2024 Financial Results and Revised 2024 Outlook
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare Hldgs Analyst Ratings
Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare Holdings (AVAH) Was Downgraded to a Sell Rating at J.P. Morgan
Aveanna Healthcare Hldgs Analyst Ratings
UBS Initiates Coverage on Aveanna Healthcare With Sell Rating, $1.50 Price Target
No Data
No Data